MMIT Strategic Launch Report provides drug manufacturers with a realistic view of payers’ coverage adoption rates and utilization management within the first year post-launch.
Use Strategic Launch Report to:
- Predict one-year uptake of a pipeline agent
- Outline payer and channel segmentation
- Highlight potential obstacles from new drug launch policies
- Inform speed of decision-making